 STONY BROOK, N.Y.--BUSINESS WIRE--- APDN COVID19--Applied DNA Sciences, Inc. NASDAQ:APDN Applied DNA or the Company, a leader in Polymerase Chain Reaction PCR-based DNA manufacturing, announced that the U.S. Food and Drug Administration FDA has granted an Emergency Use Authorization EUA amendment that expands the installed base of RT-PCR platforms that can process the Companys LineaTM COVID-19 Assay Kit. The EUA amendment extends the RT-PCR platform authorization from Applied Biosystems Therm 